Title : Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.

Pub. Date : 2018 Jan 1

PMID : 29061643






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Motolimod plus cetuximab also decreased induction of Treg and reduced markers of suppression, including CTLA-4, CD73, and membrane-bound TGFbeta. VTX-2337 5'-nucleotidase ecto Homo sapiens